A detailed history of Groupama Asset Managment transactions in Merck & Co., Inc. stock. As of the latest transaction made, Groupama Asset Managment holds 1,554,497 shares of MRK stock, worth $156 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares
1,554,497
Previous 1,409,536 10.28%
Holding current value
$156 Million
Previous $87.6 Billion 20.54%
% of portfolio
1.81%
Previous 1.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$111.15 - $128.97 $16.1 Million - $18.7 Million
144,961 Added 10.28%
1,554,497 $69.6 Billion
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $88.3 Million - $94.9 Million
713,494 Added 102.51%
1,409,536 $87.6 Billion
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $91.7 Million - $107 Million
-809,347 Reduced 53.76%
696,042 $98.8 Billion
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $151 Million - $164 Million
1,505,389 New
1,505,389 $83.1 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $255B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.